Samir El‐Masry

741 total citations
39 papers, 504 citations indexed

About

Samir El‐Masry is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Samir El‐Masry has authored 39 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Epidemiology and 9 papers in Hepatology. Recurrent topics in Samir El‐Masry's work include Parasites and Host Interactions (5 papers), Hepatitis C virus research (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Samir El‐Masry is often cited by papers focused on Parasites and Host Interactions (5 papers), Hepatitis C virus research (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Samir El‐Masry collaborates with scholars based in Egypt, Ireland and United States. Samir El‐Masry's co-authors include Mahmoud Lotfy, Taha Kumosani, Mohamed F. Elshal, Gamal Badra, Hany Khalil, Ahmed I. Abd El Maksoud, Hosam Zaghloul, Mohamed F. Abdelhameed, Imam Waked and Roba M. Talaat and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Microbiology and Journal of Lipid Research.

In The Last Decade

Samir El‐Masry

39 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samir El‐Masry Egypt 11 120 111 80 68 66 39 504
Ingrid Pruimboom‐Brees United States 11 53 0.4× 166 1.5× 63 0.8× 25 0.4× 31 0.5× 15 751
Renyong Guo China 13 124 1.0× 265 2.4× 188 2.4× 40 0.6× 54 0.8× 24 635
Dong Hee Whang South Korea 17 71 0.6× 87 0.8× 187 2.3× 24 0.4× 86 1.3× 56 876
Pascal Vincent France 14 452 3.8× 62 0.6× 124 1.6× 71 1.0× 11 0.2× 33 727
Ankur Pandey United States 17 126 1.1× 106 1.0× 155 1.9× 93 1.4× 8 0.1× 51 804
Donatella Pellati Italy 9 44 0.4× 209 1.9× 80 1.0× 128 1.9× 180 2.7× 14 816
Michelle S. M. A. Damen United States 14 79 0.7× 140 1.3× 206 2.6× 71 1.0× 7 0.1× 28 653
Mehmet Sami Serin Türkiye 16 85 0.7× 308 2.8× 275 3.4× 61 0.9× 5 0.1× 53 843
Duck Jin Hong South Korea 11 58 0.5× 182 1.6× 127 1.6× 27 0.4× 82 1.2× 16 612
C. Gilmore United Kingdom 13 29 0.2× 90 0.8× 138 1.7× 105 1.5× 23 0.3× 15 788

Countries citing papers authored by Samir El‐Masry

Since Specialization
Citations

This map shows the geographic impact of Samir El‐Masry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samir El‐Masry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samir El‐Masry more than expected).

Fields of papers citing papers by Samir El‐Masry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samir El‐Masry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samir El‐Masry. The network helps show where Samir El‐Masry may publish in the future.

Co-authorship network of co-authors of Samir El‐Masry

This figure shows the co-authorship network connecting the top 25 collaborators of Samir El‐Masry. A scholar is included among the top collaborators of Samir El‐Masry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samir El‐Masry. Samir El‐Masry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Masry, Samir, et al.. (2025). Epigallocatechin-3-gallate inhibits replication of influenza A virus via restoring the host methylated genes following infection. International Microbiology. 28(7). 1843–1855. 2 indexed citations
2.
Mansour, Nahla A., et al.. (2022). Nanoparticles for active combination radio mitigating agents of zinc coumarate and zinc caffeinate in a rat model. Environmental Science and Pollution Research. 29(20). 30233–30248. 1 indexed citations
3.
El‐Masry, Samir, et al.. (2022). mir-146a genetic polymorphisms in systemic lupus erythematosus patients: Correlation with disease manifestations. Non-coding RNA Research. 7(3). 142–149. 8 indexed citations
4.
El‐Masry, Samir, et al.. (2021). Association of MTHFR and TYMS gene polymorphisms with the susceptibility to HCC in Egyptian HCV cirrhotic patients. Clinical and Experimental Medicine. 22(2). 257–267. 3 indexed citations
5.
El‐Masry, Samir, et al.. (2019). Detection of antibiotic susceptibility by colorimetric minimum inhibitory concentration in staphylococcal isolates. Journal of Applied Microbiology. 127(3). 693–700. 17 indexed citations
6.
7.
Said, Samy B., et al.. (2015). Prevalence and Prognostic Impact of CEBPA Gene Mutation (Simplified Assay Technique) in Egyptian Acute Myeloid Leukemia Patients with Normal Cytogenetics. Indian Journal of Hematology and Blood Transfusion. 32(4). 405–411. 3 indexed citations
8.
El‐Masry, Samir, et al.. (2015). Role of oxidant–antioxidant imbalance in the pathogenesis of chronic obstructive pulmonary disease. SHILAP Revista de lepidopterología. 64(4). 813–820. 17 indexed citations
9.
Talaat, Roba M., et al.. (2014). Circulating pro‐ and anti‐angiogenic mediators in patients infected with hepatitis C at different stages of hepatocellular carcinoma. Journal of Medical Virology. 86(7). 1120–1129. 6 indexed citations
10.
Sofan, Mamdouh A., et al.. (2014). NPM1 Gene Mutation in Egyptian Patients with Cytogenetically Normal Acute Myeloid Leukemia. Clinical Laboratory. 60(11/2014). 1813–22. 8 indexed citations
11.
El‐Masry, Samir, et al.. (2010). Helicobacter pylori and Hepatitis C virus coinfection in Egyptian patients. Journal of Global Infectious Diseases. 2(1). 4–4. 30 indexed citations
12.
El‐Masry, Samir, et al.. (2010). Pattern of matrix metalloproteinases-9, P53 and BCL-2 proteins in Egyptian patients with pulmonaryMycobacterium tuberculosis. Acta Microbiologica et Immunologica Hungarica. 57(2). 123–133. 6 indexed citations
13.
Elshal, Mohamed F., et al.. (2008). Sperm head defects and disturbances in spermatozoal chromatin and DNA integrities in idiopathic infertile subjects: Association with cigarette smoking. Clinical Biochemistry. 42(7-8). 589–594. 76 indexed citations
14.
El‐Masry, Samir, et al.. (2008). Value of serum anti-p53 antibodies as a prognostic factor in Egyptian patients with hepatocellular carcinoma. Clinical Biochemistry. 41(14-15). 1131–1139. 30 indexed citations
15.
16.
El‐Masry, Samir, et al.. (2006). Serum laminin assayed by Slot-Blot-ELISA in patients with combined viral hepatitis C and schistosomiasis. Clinical Biochemistry. 39(6). 652–657. 5 indexed citations
17.
El‐Masry, Samir, et al.. (2005). Relationship of Helicobacter pylori to Bcl-2 Family Expression, DNA Content, and Pathological Characteristics of Gastric Cancer. International Journal of Gastrointestinal Cancer. 36(2). 61–68. 9 indexed citations
18.
El‐Masry, Samir, et al.. (2004). Different cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni.. PubMed. 11(1). 23–9. 8 indexed citations
19.
El‐Masry, Samir, et al.. (2003). DNA strand scission by Fe(III) 2‐methylaminopyridine complex and hydrogen peroxide. Biotechnology and Applied Biochemistry. 38(3). 253–256. 2 indexed citations
20.
Shaaban, Atallah A., et al.. (1991). Cytokeratin Shedding in Urine as a Biological Marker for Bladder Cancer: Monoclonal Antibody‐Based Evaluation. British Journal of Urology. 68(3). 248–253. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ingrid Pruimboom‐Brees Breakdown of academic impact, for papers by Renyong Guo Breakdown of academic impact, for papers by Dong Hee Whang Breakdown of academic impact, for papers by Pascal Vincent Breakdown of academic impact, for papers by Ankur Pandey Breakdown of academic impact, for papers by Donatella Pellati Breakdown of academic impact, for papers by Michelle S. M. A. Damen Breakdown of academic impact, for papers by Mehmet Sami Serin Breakdown of academic impact, for papers by Duck Jin Hong Breakdown of academic impact, for papers by C. Gilmore
Rankless by CCL
2026